Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

11062	Companies
242646	Keywords
170892	Articles
130605	Press releases

Home
Companies
Biophytis

PRESS RELEASE

published on 07/01/2024 at 07:00, 2 years 2 months ago

Biophytis presented its Phase 2-3 COVA study results in severe forms of Covid-19 at the WCID in Paris
Biophytis presents positive results from Phase 2-3 COVA study for severe Covid-19 at WCID Paris. Bio101 shows significant efficacy and safety in reducing risk of respiratory failure and death

Biophytis COVID-19 Positive Results Phase 2-3 COVA Study Respiratory Failure
PRESS RELEASE

published on 07/01/2024 at 07:00, 2 years 2 months ago

Biophytis a présenté les résultats de l'étude COVA de phase 2-3 dans les formes sévères de Covid-19 lors du WCID à Paris
Biophytis présente les résultats de l'étude COVA de phase 2-3 sur le traitement du Covid-19 lors du WCID à Paris. Les résultats sont positifs avec réduction significative des risques

Biophytis COVID-19 COVA Résultats Phase 2-3
REGULATED PRESS RELEASE

published on 07/01/2024 at 07:00, 2 years 2 months ago

Biophy(s a présenté les résultats de l'étude COVA de phase 2-3 dans les formes sévères de Covid-19 lors du WCID à Paris
Biophytis présente les résultats de l'étude COVA de phase 2-3 sur les formes sévères de Covid-19 lors du WCID à Paris. Des résultats positifs de réduction du risque de défaillance respiratoire et de mortalité sont révélés

Biophytis COVID-19 Résultats Positifs Étude COVA Réduction Du Risque De Mortalité
REGULATED PRESS RELEASE

published on 07/01/2024 at 07:00, 2 years 2 months ago

Biophytis presented its Phase 2-3 COVA study results in severe forms of Covid-19 at the WCID in Paris
Biophytis presented positive results of its Phase 2-3 COVA study for severe Covid-19 at WCID in Paris, showing reduction in respiratory failure and death rates

Biophytis COVID-19 Positive Results Phase 2-3 COVA Study
BRIEF

published on 06/25/2024 at 23:05, 2 years 2 months ago

Biophytis Approves All Resolutions at General Meeting

Shareholders Biophytis General Meeting Resolutions
BRIEF

published on 06/25/2024 at 23:05, 2 years 2 months ago

Résultats de l'Assemblée Générale Mixte de Biophytis du 24 juin 2024

Biophytis Assemblée Générale Resolutions Quorum Vote
REGULATED PRESS RELEASE

published on 06/25/2024 at 23:00, 2 years 2 months ago

RESULTS OF THE COMBINED GENERAL MEETING ON JUNE 24, 2024
Biophytis SA announces the approval of all resolutions at the combined general meeting held on June 24, 2024, with significant shareholder participation

Shareholders General Meeting Resolutions Approval Biophytis SA
REGULATED PRESS RELEASE

published on 06/25/2024 at 23:00, 2 years 2 months ago

RÉSULTATS DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 24 JUIN 2024
Biophytis annonce l'approbation des résolutions lors de l'Assemblée Générale Mixte du 24 Juin 2024. Détails des décisions et perspectives de la société

Biophytis Biotechnologie Assemblée Générale Mixte Approbation Des Résolutions Développement De Traitements
BRIEF

published on 06/20/2024 at 07:05, 2 years 3 months ago

Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine

Biophytis Partenariat Amérique Latine BIO101 Blanver
BRIEF

published on 06/20/2024 at 07:05, 2 years 3 months ago

Biophytis Grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at Up to €108 Million

Biophytis Pharmaceuticals Latin America BIO101 Blanver

Accesswire

Published on 09/23/2026 at 15:42, 2 hours 13 minutes ago

Global Atomic Announces C$50 Million Public Offering of Units
Published on 09/23/2026 at 14:31, 3 hours 24 minutes ago

First Breach Completes First Untethered Flight of Proprietary Drone Prototype, Advancing American-Made Unmanned Systems Program
Published on 09/23/2026 at 14:30, 3 hours 25 minutes ago

Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides
Published on 09/23/2026 at 14:00, 3 hours 55 minutes ago

Integrated Rewards Launches "Celebrate Canadian" Campaign to Connect Canadian Brands with Millions of Consumers
Published on 09/23/2026 at 13:30, 4 hours 25 minutes ago

Engineering Cost Study Validates Commercial-Scale U.S. HPMSM Capital Cost and Establishes EMM Capital Cost for Electric Metals' North Star Manganese Project

View all ACCESSWIRE

EQS Group

Published on 09/23/2026 at 17:30, 24 minutes ago

Disclosure of significant holding of Reinet Investments S.C.A. shares
Published on 09/23/2026 at 16:55, 59 minutes ago

Bird.com secures $450m financing as it launches communications infrastructure for AI agents
Published on 09/23/2026 at 16:40, 1 hour 14 minutes ago

Xryma Plc Goes Live on the ECB T2 Real-Time Gross Settlement Network
Published on 09/23/2026 at 16:30, 1 hour 24 minutes ago

nobilia and Coohom Forge Strategic Global Partnership to Redefine the Future of Kitchen Planning with Spatial Intelligence
Published on 09/23/2026 at 15:42, 2 hours 12 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.

Les Echos

Published on 09/23/2026 at 17:45, 10 minutes ago

Report on share repurchases from 16 to 21 September 2026
Published on 09/23/2026 at 17:45, 10 minutes ago

Déclaration des transactions sur actions propres réalisées du 16 au 21 septembre 2026
Published on 09/23/2026 at 17:45, 10 minutes ago

Infotel : H1 2026 RESULTS. Revenue growth of +9.4%.
Published on 09/23/2026 at 17:45, 10 minutes ago

Infotel : RÉSULTATS SEMESTRIELS 2026. Croissance de + 9,4 % du chiffre d’affaires.
Published on 09/23/2026 at 17:45, 10 minutes ago

Entech : Résultats du 1er semestre 2026.

View all LES ECHOS COMFI WIRE